Skip to content
OpenCapital
Get started

10x Genomics, Inc. TXG Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

TEC
Bio-TechneTECH
$14.18M+0.9%
Illumina logo
IlluminaILMN
$80M+2.6%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$10.44M-31.4%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$36.2M-12.3%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$12.64M+34.2%
Agilent Technologies logo
Agilent TechnologiesA
$187M-1.1%

Other financials

Income statement

See full
Revenue$150.8M-2.6%
Gross profit$106.2M+0.7%
Operating income-$17.0M+56.7%
Net income-$13.5M+60.8%
EPS (diluted)-$0.10+64.3%

Balance sheet

See full
Cash & equivalents$490.3M+30.0%
Total debt$81.4M+1.6%
Total equity$814.3M+15.2%
Total assets$1.0B+12.4%

Cash flow

See full
Operating cash flow$26.1M-24.0%
CapEx$1.6M-15.6%
Free cash flow$24.5M-24.4%

Valuation

See full
Market cap$4.41B+154%
Enterprise value$4B+199%
P/S6.9×+4.1×

Profitability

See full
Gross margin69.6%+1.2pp
Operating margin-6.1%-2.7pp
Net margin-3.5%-1.6pp
FCF margin19.1%—

Returns & leverage

See full
Return on equity-3%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 10x Genomics, Inc.'s operating lease liabilities (current)?
10x Genomics, Inc. (TXG) reported operating lease liabilities (current) of $11.33M in Q1 2026.
How has 10x Genomics, Inc.'s operating lease liabilities (current) changed year-over-year?
10x Genomics, Inc.'s operating lease liabilities (current) increased by 20.0% year-over-year, from $9.44M to $11.33M.
What is the long-term trend for 10x Genomics, Inc.'s operating lease liabilities (current)?
Over 5 years (2020 to 2025), 10x Genomics, Inc.'s operating lease liabilities (current) has grown at a 13.1% compound annual growth rate (CAGR), from $5.94M to $10.99M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.